ACADIAN ASSET MANAGEMENT LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 1 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$94
-73.1%
160,347
-82.2%
0.00%
-100.0%
Q4 2022$349
-100.0%
899,514
+99.6%
0.00%
-50.0%
Q2 2022$712,000450,6960.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2023
NameSharesValueWeighting ↓
Murchinson Ltd. 500,005$5,050,0000.97%
GSA CAPITAL PARTNERS LLP 50,800$80,0000.01%
XTX Topco Ltd 18,596$29,0000.01%
ACADIAN ASSET MANAGEMENT LLC 450,696$712,0000.00%
Renaissance Technologies 643,124$1,016,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 30,454$48,0000.00%
Federation des caisses Desjardins du Quebec 158$2500.00%
FMR LLC 2,131$3,0000.00%
DIMENSIONAL FUND ADVISORS LP 12,810$20,0000.00%
Focused Wealth Management, Inc 22$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders